Report Detail
Global Lyme Disease Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4527925 |
- 12 April, 2023 |
- Global |
- 100 Pages |
- GIR (Global Info Research) |
- Service & Software
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
According to our (Global Info Research) latest study, the global Lyme Disease Testing market size was valued at USD 206.3 million in 2022 and is forecast to a readjusted size of USD 316.6 million by 2029 with a CAGR of 6.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
This report is a detailed and comprehensive analysis for global Lyme Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lyme Disease Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Lyme Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Lyme Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Lyme Disease Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lyme Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lyme Disease Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific and IGeneX, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Lyme Disease Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ELISA
Western Blotting
PCR
Others
Market segment by Application
Hospital and Testing Agency
Personal
Market segment by players, this report covers
Quidel Corporation
Roche Holding AG
Fujirebio(H.U. Group Holdings)
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Lyme Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lyme Disease Testing, with revenue, gross margin and global market share of Lyme Disease Testing from 2018 to 2023.
Chapter 3, the Lyme Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Lyme Disease Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Lyme Disease Testing.
Chapter 13, to describe Lyme Disease Testing research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Lyme Disease Testing
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Lyme Disease Testing by Type
- 1.3.1 Overview: Global Lyme Disease Testing Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Lyme Disease Testing Consumption Value Market Share by Type in 2022
- 1.3.3 ELISA
- 1.3.4 Western Blotting
- 1.3.5 PCR
- 1.3.6 Others
- 1.4 Global Lyme Disease Testing Market by Application
- 1.4.1 Overview: Global Lyme Disease Testing Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital and Testing Agency
- 1.4.3 Personal
- 1.5 Global Lyme Disease Testing Market Size & Forecast
- 1.6 Global Lyme Disease Testing Market Size and Forecast by Region
- 1.6.1 Global Lyme Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Lyme Disease Testing Market Size by Region, (2018-2029)
- 1.6.3 North America Lyme Disease Testing Market Size and Prospect (2018-2029)
- 1.6.4 Europe Lyme Disease Testing Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Lyme Disease Testing Market Size and Prospect (2018-2029)
- 1.6.6 South America Lyme Disease Testing Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Lyme Disease Testing Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Quidel Corporation
- 2.1.1 Quidel Corporation Details
- 2.1.2 Quidel Corporation Major Business
- 2.1.3 Quidel Corporation Lyme Disease Testing Product and Solutions
- 2.1.4 Quidel Corporation Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Quidel Corporation Recent Developments and Future Plans
- 2.2 Roche Holding AG
- 2.2.1 Roche Holding AG Details
- 2.2.2 Roche Holding AG Major Business
- 2.2.3 Roche Holding AG Lyme Disease Testing Product and Solutions
- 2.2.4 Roche Holding AG Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Roche Holding AG Recent Developments and Future Plans
- 2.3 Fujirebio(H.U. Group Holdings)
- 2.3.1 Fujirebio(H.U. Group Holdings) Details
- 2.3.2 Fujirebio(H.U. Group Holdings) Major Business
- 2.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product and Solutions
- 2.3.4 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Fujirebio(H.U. Group Holdings) Recent Developments and Future Plans
- 2.4 ZEUS Scientific
- 2.4.1 ZEUS Scientific Details
- 2.4.2 ZEUS Scientific Major Business
- 2.4.3 ZEUS Scientific Lyme Disease Testing Product and Solutions
- 2.4.4 ZEUS Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 ZEUS Scientific Recent Developments and Future Plans
- 2.5 IGeneX
- 2.5.1 IGeneX Details
- 2.5.2 IGeneX Major Business
- 2.5.3 IGeneX Lyme Disease Testing Product and Solutions
- 2.5.4 IGeneX Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 IGeneX Recent Developments and Future Plans
- 2.6 Thermo Fisher Scientific
- 2.6.1 Thermo Fisher Scientific Details
- 2.6.2 Thermo Fisher Scientific Major Business
- 2.6.3 Thermo Fisher Scientific Lyme Disease Testing Product and Solutions
- 2.6.4 Thermo Fisher Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
- 2.7 Everlywell
- 2.7.1 Everlywell Details
- 2.7.2 Everlywell Major Business
- 2.7.3 Everlywell Lyme Disease Testing Product and Solutions
- 2.7.4 Everlywell Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Everlywell Recent Developments and Future Plans
- 2.8 Oxford Immunotec Global PLC(PerkinElmer)
- 2.8.1 Oxford Immunotec Global PLC(PerkinElmer) Details
- 2.8.2 Oxford Immunotec Global PLC(PerkinElmer) Major Business
- 2.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product and Solutions
- 2.8.4 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Developments and Future Plans
- 2.9 BioMerieux
- 2.9.1 BioMerieux Details
- 2.9.2 BioMerieux Major Business
- 2.9.3 BioMerieux Lyme Disease Testing Product and Solutions
- 2.9.4 BioMerieux Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 BioMerieux Recent Developments and Future Plans
- 2.10 Bio-Rad Laboratories
- 2.10.1 Bio-Rad Laboratories Details
- 2.10.2 Bio-Rad Laboratories Major Business
- 2.10.3 Bio-Rad Laboratories Lyme Disease Testing Product and Solutions
- 2.10.4 Bio-Rad Laboratories Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
- 2.11 T2 Biosystems
- 2.11.1 T2 Biosystems Details
- 2.11.2 T2 Biosystems Major Business
- 2.11.3 T2 Biosystems Lyme Disease Testing Product and Solutions
- 2.11.4 T2 Biosystems Lyme Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 T2 Biosystems Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Lyme Disease Testing Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Lyme Disease Testing by Company Revenue
- 3.2.2 Top 3 Lyme Disease Testing Players Market Share in 2022
- 3.2.3 Top 6 Lyme Disease Testing Players Market Share in 2022
- 3.3 Lyme Disease Testing Market: Overall Company Footprint Analysis
- 3.3.1 Lyme Disease Testing Market: Region Footprint
- 3.3.2 Lyme Disease Testing Market: Company Product Type Footprint
- 3.3.3 Lyme Disease Testing Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Lyme Disease Testing Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Lyme Disease Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Lyme Disease Testing Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Lyme Disease Testing Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Lyme Disease Testing Consumption Value by Type (2018-2029)
- 6.2 North America Lyme Disease Testing Consumption Value by Application (2018-2029)
- 6.3 North America Lyme Disease Testing Market Size by Country
- 6.3.1 North America Lyme Disease Testing Consumption Value by Country (2018-2029)
- 6.3.2 United States Lyme Disease Testing Market Size and Forecast (2018-2029)
- 6.3.3 Canada Lyme Disease Testing Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Lyme Disease Testing Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Lyme Disease Testing Consumption Value by Type (2018-2029)
- 7.2 Europe Lyme Disease Testing Consumption Value by Application (2018-2029)
- 7.3 Europe Lyme Disease Testing Market Size by Country
- 7.3.1 Europe Lyme Disease Testing Consumption Value by Country (2018-2029)
- 7.3.2 Germany Lyme Disease Testing Market Size and Forecast (2018-2029)
- 7.3.3 France Lyme Disease Testing Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Lyme Disease Testing Market Size and Forecast (2018-2029)
- 7.3.5 Russia Lyme Disease Testing Market Size and Forecast (2018-2029)
- 7.3.6 Italy Lyme Disease Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Lyme Disease Testing Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Lyme Disease Testing Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Lyme Disease Testing Market Size by Region
- 8.3.1 Asia-Pacific Lyme Disease Testing Consumption Value by Region (2018-2029)
- 8.3.2 China Lyme Disease Testing Market Size and Forecast (2018-2029)
- 8.3.3 Japan Lyme Disease Testing Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Lyme Disease Testing Market Size and Forecast (2018-2029)
- 8.3.5 India Lyme Disease Testing Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Lyme Disease Testing Market Size and Forecast (2018-2029)
- 8.3.7 Australia Lyme Disease Testing Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Lyme Disease Testing Consumption Value by Type (2018-2029)
- 9.2 South America Lyme Disease Testing Consumption Value by Application (2018-2029)
- 9.3 South America Lyme Disease Testing Market Size by Country
- 9.3.1 South America Lyme Disease Testing Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Lyme Disease Testing Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Lyme Disease Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Lyme Disease Testing Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Lyme Disease Testing Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Lyme Disease Testing Market Size by Country
- 10.3.1 Middle East & Africa Lyme Disease Testing Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Lyme Disease Testing Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Lyme Disease Testing Market Size and Forecast (2018-2029)
- 10.3.4 UAE Lyme Disease Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Lyme Disease Testing Market Drivers
- 11.2 Lyme Disease Testing Market Restraints
- 11.3 Lyme Disease Testing Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Lyme Disease Testing Industry Chain
- 12.2 Lyme Disease Testing Upstream Analysis
- 12.3 Lyme Disease Testing Midstream Analysis
- 12.4 Lyme Disease Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Lyme Disease Testing. Industry analysis & Market Report on Lyme Disease Testing is a syndicated market report, published as Global Lyme Disease Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Lyme Disease Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
